Research Group Metabolism (META)

The META research group is studying metabolic diseases (e.g. type 2 diabetes and cardiovascular diseases). We use statistical, bioinformatical and machine learning approaches to integrate metabolomics, transcriptomics, epigenomics, genomics data, and information from public databases to better understand the pathophysiological mechanisms. This helps us to identify candidate biomarkers and drug targets, with the final goal to translate our discoveries into clinical practice.